EXANE DERIVATIVES - I MAB ownership

Back to all holdings Add to watchlist

I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 97 filers reported holding I MAB in Q2 2022. The put-call ratio across all filers is 1.60 and the average weighting 1.3%.

Links

Filings

External links

Quarter-by-quarter ownership

EXANE DERIVATIVES ownership history of I MAB
	Value		Shares		Weighting
Q2 2022	$158,000	-30.4%	14	0.0%	0.00%	–
Q1 2022	$227,000	-65.8%	14	0.0%	0.00%	–
Q4 2021	$663,000	-34.7%	14	0.0%	0.00%	–
Q3 2021	$1,015,000	-99.6%	14	-99.6%	0.00%	-100.0%
Q2 2021	$287,300,000	+57.5%	3,764	0.0%	0.06%	+25.0%
Q1 2021	$182,433,000	–	3,764	–	0.05%	–
Download

Other shareholders

I MAB shareholders Q2 2022
Name	Shares	Value	Weighting ↓
EDBI Pte Ltd	222,136	$768,591	0.86%
HHLR ADVISORS, LTD.	6,954,442	$24,062,369	0.43%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	310,499	$1,074,327	0.30%
Maso Capital Partners Ltd	100,000	$346	0.23%
Artal Group S.A.	850,000	$2,941	0.18%
Virtus ETF Advisers LLC	26,347	$91,161	0.05%
GSA CAPITAL PARTNERS LLP	96,555	$334	0.03%
CAXTON ASSOCIATES LP	53,793	$186,124	0.03%
Diametric Capital, LP	13,924	$48,177	0.02%
Tekla Capital Management LLC	162,580	$562,527	0.02%

View complete list of I MAB shareholders